{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:39:24Z","timestamp":1781332764382,"version":"3.54.1"},"reference-count":22,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20150508"],"award-info":[{"award-number":["20150508"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["2018-1256 (LDF) and 2019-0536 (EE)"],"award-info":[{"award-number":["2018-1256 (LDF) and 2019-0536 (EE)"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["540-2013-8797, 2016-02043 (TS), 2019-05901 (LDF)"],"award-info":[{"award-number":["540-2013-8797, 2016-02043 (TS), 2019-05901 (LDF)"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The National Research Foundation of China","award":["81361138019"],"award-info":[{"award-number":["81361138019"]}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2020,10,20]]},"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1183\/13993003.03463-2020","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T18:00:41Z","timestamp":1604599241000},"page":"2003463","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Suboptimal moxifloxacin and levofloxacin drug exposure during treatment of patients with multidrug-resistant tuberculosis: results from a prospective study in China"],"prefix":"10.1183","volume":"57","author":[{"given":"Lina","family":"Davies Forsman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Niward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Kuhlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xubin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Werngren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6069-3564","authenticated-orcid":false,"given":"Jakob","family":"Paues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3424-9686","authenticated-orcid":false,"given":"Ulrika S.H.","family":"Simonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Eliasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Hoffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem","family":"Alffenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Bruchfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"2026061109104689000_57.3.2003463.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02107-2018"},{"key":"2026061109104689000_57.3.2003463.2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00176610"},{"key":"2026061109104689000_57.3.2003463.3","doi-asserted-by":"crossref","first-page":"S293","DOI":"10.1093\/cid\/ciy611","article-title":"Levofloxacin pharmacokinetics\/pharmacodynamics, dosing, susceptibility breakpoints, and artificial intelligence in the treatment of multidrug-resistant tuberculosis","volume":"67","author":"Deshpande","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2026061109104689000_57.3.2003463.4","doi-asserted-by":"publisher","DOI":"10.1086\/424849"},{"key":"2026061109104689000_57.3.2003463.5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023899"},{"key":"2026061109104689000_57.3.2003463.6","doi-asserted-by":"crossref","first-page":"122397","DOI":"10.1016\/j.jchromb.2020.122397","article-title":"Development and validation of a simple LC-MS\/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma","volume":"1158","author":"Zheng X","year":"2020","journal-title":"J Chromatogr B"},{"key":"2026061109104689000_57.3.2003463.7","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.18.0622"},{"key":"2026061109104689000_57.3.2003463.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.10.012"},{"key":"2026061109104689000_57.3.2003463.9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01478-13"},{"key":"2026061109104689000_57.3.2003463.10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit352"},{"key":"2026061109104689000_57.3.2003463.11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu572"},{"key":"2026061109104689000_57.3.2003463.12","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3937"},{"key":"2026061109104689000_57.3.2003463.13","unstructured":"World Health Organization . The WHO Consolidated Guidelines on Drug-resistant Tuberculosis. www.who.int\/tb\/publications\/2019\/consolidated-guidelines-drug-resistant-TB-treatment\/en\/ Date last updated: 2009. Date last accessed: 1 Sept 2020."},{"key":"2026061109104689000_57.3.2003463.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811867"},{"key":"2026061109104689000_57.3.2003463.15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00173-2017"},{"key":"2026061109104689000_57.3.2003463.16","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01092-18"},{"key":"2026061109104689000_57.3.2003463.17","doi-asserted-by":"crossref","first-page":"e00384-00319","DOI":"10.1128\/AAC.00384-19","article-title":"Limited sampling strategies using linear regression and the bayesian approach for therapeutic drug monitoring of moxifloxacin in tuberculosis patients","volume":"63","author":"van den Elsen","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2026061109104689000_57.3.2003463.18","unstructured":"World Health Organization . Technical Report on the Pharmacokinetics and Pharmacodynamics (PK\/PD) of Medicines used in the Treatment of Drug-resistant Tuberculosis. www.who.int\/iris\/handle\/10665\/260440 Date last accessed: 1 Sept 2020."},{"key":"2026061109104689000_57.3.2003463.19","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01522-2019"},{"key":"2026061109104689000_57.3.2003463.20","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00770-18"},{"key":"2026061109104689000_57.3.2003463.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30190-6"},{"key":"2026061109104689000_57.3.2003463.22","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/cid\/ciy1068","article-title":"Minimum inhibitory concentrations of fluoroquinolones and pyrazinamide susceptibility correlate to clinical improvement in MDR-TB patients \u2013 a nationwide Swedish cohort study over two decades","volume":"69","author":"Davies Forsman","year":"2019","journal-title":"Clin Infect Dis"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.03463-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:11:08Z","timestamp":1781194268000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.03463-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,11]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1183\/13993003.03463-2020"],"URL":"https:\/\/doi.org\/10.1183\/13993003.03463-2020","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]}}}